In breast cancer, miR-494 indirectly downregulates TFPI2 by modulating E74-like factor 1 (ELF-1) and aryl hydrocarbon receptor (AHR), promoting tumor growth [78]. This evidence concerns the gene ELF1 and breast carcinoma.